doi: 10.3389/fmolb.2022.965064 70
1425-C INTERFERON-BASED THERAPIES ARE BENEFICIAL IN CIRRHOTIC HEPATITIS B PATIENTS WITH GOOD LIVER FUNCTION RESERVE: REAL-WORLD EVIDENCE FROM OASIS PROJECT 2.5-YEAR DATA Qiran Zhang 1 , Feng Sun 1 , Yiqi Yu 1 , Shulan Sui 1 , Tingting Zhao 1 , Ying Guo 2 , Wanhua Ren 3 , Jiming Zhang 4 , Yuxian Huang 1 and Wenhong Zhang 1 , (1)Huashan Hospital, Shanghai Medical College, Fudan University, (2)The Third Peoples Hospital of Taiyuan, Taiyuan, China, (3)Shandong Provincial Hospital Affiliated to Shandong University, (4)Fudan University Background: Interferon (IFN)-based therapies are considered effective in functional cure and reducing hepatocellular carcinoma (HCC) risks in patients with chronic hepatitis B (CHB)

also showed the same trend in knee symptoms and daily activity progression using the mean KOOS score in ten participants with degenerative meniscus tears without osteoarthritis according to Stoller classification after 3 months and 6 months of follow up (i.e., KOOS: 56.6 15.7 baseline, 70.2 16.8 post- 3 months, 72.7 18.5 post- 6 months, p = 0.0007)
Glutathione is a tripeptide antioxidant produced by our bodies that plays a really important role in protecting our proteins and DNA from damage caused by free radicals and oxidative stress
Is this for injection or topical use